Oscotec vs Torrent Pharmaceuticals: Fair Value & Quality
Both stocks run through our valuation models. Here is how Oscotec (039200) and Torrent Pharmaceuticals (500420) compare, as of Aug 15, 2026.
As of Aug 15, 2026, Fair Value Calculator sees Torrent Pharmaceuticals as the less overvalued of the two: Oscotec trades at KRW 37,400 versus a fair value of KRW 33,210 (-11%), while Torrent Pharmaceuticals trades at ₹4,840 versus ₹4,360 (-10%).
Oscotec
039200.KQ · KRW · Health Care
-11%
upside to fair value
overvalued
PriceKRW 37,400
Fair ValueKRW 33,210
Quality72/100
Torrent Pharmaceuticals
500420.BSE · INR · Health Care
-10%
upside to fair value
fairly valued
Price₹4,840
Fair Value₹4,360
Quality53/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
OscotecTorrent Pharmaceuticals
Valuation
—P/E (TTM)37.8×
0.17×P/S (TTM)—
—P/B0.05×
—EV/EBITDA3.8×
Profitability
0%Net margin0%
—Operating margin0%
36%Return on equity—
-29%Return on assets0%
Growth
31%Revenue growth (YoY)0%
170.2%Avg. growth/yr (3Y)12.7%
18.1%Avg. growth/yr (5Y)11.4%
Balance & size
—Debt / equity1.39×
$832MMarket cap$4B
mixedGrowth qualityhealthy
Oscotec leads: 3 to 1 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Oscotecof which business quality 72 · market factors 27Torrent Pharmaceuticalsof which business quality 52 · market factors 75
ProfitabilityMargins and returns on capital today
80
51
Quality GrowthAre margins and returns improving?
99
40
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
49
44
Low VolatilityCalm price path (market factor)
40
86
MomentumPrice trend over the last 3–12 months (market factor)
16
68
52W MomentumDistance to the 52-week high (market factor)
33
75
Net IssuanceBuybacks instead of dilution
75
82
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Oscotec
DCF ModelsKRW 35,727
Earnings-BasedKRW 65,192
MultiplesKRW 28,171
Asset-BasedKRW 4,323
Growth DCFKRW 13,214
Economic ProfitKRW 28,952
Growth EarningsKRW 86,538
14 of 24 models see the stock below the current price.
Torrent Pharmaceuticals
DCF Models₹5,769
Earnings-Based₹2,922
Multiples₹5,306
Asset-Based₹707
Growth DCF₹5,288
Economic Profit₹3,266
Growth Earnings₹5,013
9 of 24 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Oscotec
Bear KRW 21,708Fair Value KRW 33,210Bull KRW 52,707
KRW 37,400 = current price (white tick)
Torrent Pharmaceuticals
Bear ₹1,984Fair Value ₹4,360Bull ₹7,472
₹4,840 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Oscotec · Health Care
Quality score72 · Top 25%
Fair value upside-11% · above median
Torrent Pharmaceuticals · Health Care
Quality score53 · above median
Fair value upside-10% · above median
Bottom line
As of Aug 15, 2026, Fair Value Calculator sees Torrent Pharmaceuticals as the less overvalued of the two: Oscotec trades at KRW 37,400 versus a fair value of KRW 33,210 (-11%), while Torrent Pharmaceuticals trades at ₹4,840 versus ₹4,360 (-10%).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
